PATENTS related term(s) Copyrights
Analyses
Biotechnology Process Patent Protection (S. 1111), S15223 [17OC]
Articles and editorials
Battle Over Bonanza for Drug Companies, S15426 [23OC]
Costly Oversight—Fine Print in GATT Law Could Cost Zantac Users Millions, S18202 [7DE]
Drug Company Preserves Tax Break in Senate Committee, S15425 [23OC]
Drug Firms at Odds Over Patent Extension, S15427 [23OC]
Drug Firms Fight To Preserve Windfall, S15425 [23OC]
Drugs Get Extra Patent Time, S15424 [23OC]
GATT Delayed New Generic Drugs, S15429 [23OC]
GATT Puts Generic Drugs on Hold, S15429 [23OC]
Generic-Drug Talks Stall in Committee, S15425 [23OC]
Glaxo Rolls Out ``Big Bucks'' Card in GATT Battle on Capitol Hill, S15427-S15429 [23OC]
Ruling Shortens Branded Drugs' Monopoly, S15430 [23OC]
Senate Panel—No Vote on Drug Loophole, S15426 [23OC]
Senator From Glaxo?, S15426 [23OC]
Simpson Abstains Because of Stock, S15424 [23OC]
Three Drug Makers Win Suit To Extend Protection of Patents, S15422 [23OC]
Zantac Windfall, S18203 [7DE], E2436 [21DE]
Bills and resolutions
Applications: early publication (see H.R. 1733), H5608 [25MY]
Business and industry: provide credit to businesses and facilitate the transfer and commercialization of Government-owned patents and technologies (see H.R. 80), H165 [9JA]
———regulation of invention development and patent marketing services (see S. 909), S8097 [9JN]
———regulation of invention development services (see H.R. 2419), H9670 [28SE]
China, People's Republic of: protection of intellectual property rights (see H. Res. 50), H890 [30JA]
Computers: permit lawful possessors of a copy of a computer program to authorize additional copies under certain circumstances (see H.R. 533), H295 [17JA]
Courts: infringement cases relative to commercialization of inventions prior to patent filing date (see H.R. 2235), H8535 [4AU]
Drugs: ensure availability of generic drugs (see S. 1191), S12370 [11AU]
———extend protection for nonsteroidal anti-inflammatory drugs (see S. 1496; H.R. 2467), S19110 [21DE], H9897 [11OC]
Government: fairness in compensating owners (see S. 880; H.R. 632), S7696 [5JN], H537 [23JA]
———restore term (see H.R. 359), H173 [9JA]
Health: limit enforcement relative to medical and surgical procedures (see S. 1334), S15290 [18OC]
———renew and extend certain devices that aid in bodily tissue healing and reduction of pain (see H.R. 2113), H7699 [25JY]
Information services: adapt copyright laws to digital networked environments of the National Information Infrastructure (see S. 1284; H.R. 2441), S14547 [28SE], H9738 [29SE]
Medical procedures: limit issuance (see H.R. 1127), H2650 [3MR]
Patent and Trademark Office: convert to Government corporation (see S. 1458; H.R. 1659), S18232 [7DE], H5190 [17MY]
———reexamination proceedings (see S. 1070; H.R. 1732), S10655 [25JY], H5608 [25MY]
Quotation monitoring unit: renew (see H.R. 901), H1611 [10FE]
Research: biotechnology process protection (see S. 1111; H.R. 587), S11201 [2AU], H399 [19JA]
Terms: restore the proper term of patent protection (see S. 284), S1618 [26JA]
U.S. Intellectual Property Organization: establish (see H.R. 2533), H10848 [25OC]
Letters
Consumer Access to Prescription Drugs Act: Jesse Brown, Sec. of Veterans Affairs, S12391 [11AU]
———Jim Firman, Generic Drug Equity Coalition, S12391 [11AU]
———Michael Kantor, U.S. Trade Representative, S12390 [11AU]
———William B. Schultz, FDA, S12390 [11AU]
GATT implementation relative to generic drugs: C. Everett Koop, S18104 [6DE], S18209, S18211 [7DE]
———Clayton Yeutter, S18213 [7DE]
———Daniel Perry, Alliance for Aging Research, S18206 [7DE]
———Eugene P. Schonfeld, National Kidney Association, S18205 [7DE]
———Judith Simpson, United Patients' Association for Pulmonary Hypertension, Inc., S18205, S18212 [7DE]
———Leon Brittan, European Commission, S18213 [7DE]
———Patti Munter, National Organization on Fetal Alcohol Syndrome, S18205 [7DE]
———Robert J. Beall, Cystic Fibrosis Foundation, S18205 [7DE]
———Senators Dodd and Hatch, S18211 [7DE]
———several Senators, S18210 [7DE]
———William Brock, S18213 [7DE]
Mining patent claim moratorium: Representatives George Miller and Yates, H12384 [15NO]
Moratorium on mining patent claims: Thomas A. Schatz and Joe Winkelmann, Citizens Against Government Waste, H9688 [29SE]
Pharmaceutical patent extension: Cynthia Pearson, National Women's Health Network, S15430 [23OC]
———Edmund Mierzwinski, U.S. Public Interest Research Group, S15431 [23OC]
———Esther Peterson and Edmund H. Worthy, Jr., United Seniors Health Cooperative, S15431 [23OC]
———James Firman, Generic Drug Equity Coalition, S15430 [23OC]
———James Firman, National Council on the Aging, Inc., S15430 [23OC]
———James P. Love, Consumer Project on Technology, S15432 [23OC]
———Jordan Clark, United Homeowners Association, S15432 [23OC]
———Karen Fennell, American College of Nurse-Midwives, S15431 [23OC]
———Kim Youngblood, National Black Women's Health Project (organization), S15431 [23OC]
———Martha A. McSteen, National Committee To Preserve Social Security and Medicare, S15431 [23OC]
———Max Starkloff, Paraquad Inc., S15432 [23OC]
———Mern Horan, Consumer Federation of America, Gene Kimmelman, Consumers Union, and Cathy Hurwit, Citizen Action (organization), S15430 [23OC]
———Michael Calabrese, Public Citizen (organization), S15431 [23OC]
———Michael Kantor, U.S. Trade Representative, S15423 [23OC]
———Richard Fitzpatrick, National Coalition for Homeless Veterans, S15432 [23OC]
Lists
Generic Drug Equity Coalition, S12391 [11AU]
Papers
Background on the Impact of GATT Patent Extensions on the Potential Availability of Generic Zantac, S18826 [18DE]
Press releases
H.R. 1977 Still Fatally Flawed: John Kostyack and Cathy Carlson, National Wildlife Federation, H12384 [15NO]
Remarks in House
Applications: early publication (H.R. 1733), H5901 [13JN]
China, People's Republic of: protection of intellectual property rights, H2230, H2232 [27FE]
Courts: infringement cases relative to commercialization of inventions prior to patent filing date (H.R. 2235), E1680 [5AU]
Drugs: availability of generic Zantac, E2435 [21DE]
———grant certain rights for nonsteroidal anti-inflammatory drugs (H.R. 2467), E1917 [11OC]
Foreign trade: piracy of intellectual property, H843 [30JA], H3813 [28MR]
GATT: implementation, H3813 [28MR], H5899-H5903 [13JN], H6304-H6307 [26JN]
Government: fairness in compensating owners (H.R. 632), H14318, H14319 [12DE]
———restore term (H.R. 359), H183 [11JA], H554 [24JA], H3813 [28MR], H5780, H5901 [13JN], E1051 [16MY]
Information services: adapt copyright laws to digital networked environments of the National Information Infrastructure (H.R. 2441), E1892 [29SE]
Loyalty Day: observance, E908 [2MY]
Mining and mineral resources: moratorium on mining patent claims, H9685-H9695 [29SE]
———moratorium on mining patents claims, H8708, H8709 [8SE], H9641, H9663 [28SE], H12383, H12386, H12389, H12397-H12403 [15NO]
Patent and Trademark Office: convert to Government corporation (H.R. 1659), E1060 [17MY]
Research: biotechnology process protection (H.R. 587), H10095-H10098 [17OC], E129 [19JA]
Terms: restore the proper term of patent protection (H.R. 359), H6304-H6307 [26JN]
Remarks in Senate
Business and industry: regulation of invention development and patent marketing services (S. 909), S8114 [9JN]
China, People's Republic of: protection of intellectual property rights, S2149 [6FE], S2264 [7FE]
Drugs: availability of generic Zantac, S18826 [18DE]
———ensure availability of generic drugs (S. 1191), S12388 [11AU], S15421 [23OC], S16593 [2NO]
———extend protection for nonsteroidal anti-inflammatory drugs (S. 1496), S19117 [21DE]
GATT: implementation relative to generic drugs, S15421 [23OC], S16593 [2NO], S18004 [5DE], S18199-S18222 [7DE]
Government: fairness in compensating owners (S. 880), S7697 [5JN]
Health: limit enforcement relative to medical and surgical procedures (S. 1334), S15291 [18OC]
Information services: adapt copyright laws to digital networked environments of the National Information Infrastructure (S. 1284), S14550-S14553 [28SE]
Mining and mineral resources: moratorium on mining patent claims, S16382 [31OC]
———moratorium on mining patents claims, S16752 [7NO]
———provide for royalty payments and specify reclamation requirements for mining activities on Federal lands, S11866-S11877 [8AU]
Patent and Trademark Office: convert to Government corporation (S. 1458), S18234 [7DE]
———reexamination proceedings (S. 1070), S10655 [25JY]
Research: biotechnology process protection (S. 1111), S11207 [2AU], S14569 [28SE], S15220-S15222 [17OC]
Terms: restore the proper term of patent protection (S. 284), S1622 [26JA]
Reports filed
Biotechnology Patent Process Protection: Committee on the Judiciary (Senate) (S. 1111), S13728 [18SE]
Biotechnology Process Patents Protection: Committee on the Judiciary (House) (H.R. 587) (H. Rept. 104-178), H6829 [11JY]
Fairness in Compensating Patent Owners: Committee on the Judiciary (House) (H.R. 632) (H. Rept. 104-373), H13869 [30NO]
Statements
The Pledge of Allegiance: Red Skelton, E787 [5AP]
Summaries
Consumer Access to Prescription Drugs Act (S. 1191), S12390 [11AU]
Economic Impact of GATT Patent Extension on Currently Marketed Drugs: University of Minnesota College of Pharmacy, S15424 [23OC]
Texts of
H.R. 587, biotechnology process patent protection, H10095 [17OC]
H.R. 632, fairness in compensating patent owners, H14318 [12DE]
S. 284, restore the proper term of patent protection, S1623 [26JA]
S. 909, Inventor Protection Act, S8115-S8117 [9JN]
S. 1070, Patent Reexamination Reform Act, S10656 [25JY]
S. 1111, biotechnology process patent protection, S14569 [28SE], S15222 [17OC], H10098 [17OC]
S. 1191, Consumer Access to Prescription Drugs Act, S12389 [11AU]
S. 1284, National Information Infrastructure Copyright Protection Act, S14551 [28SE]
S. 1458, Patent and Trademark Office Reform Act, S18235-S18240 [7DE]
Transcripts
Pharmaceutical Patent Extension: Lisa Meyers, NBC Nightly News, S15426 [23OC]